| Cougar Biotechnology Presents Positive CB7630 Phase I and Phase II ... http://news.moneycentral.ms... Biotechnology Articles MSN MoneyCentral - Cougar Biotechnology, Inc. CGRB today announced that results from ongoing Phase I and Phase II clinical trials of Cougar's investigational drug, CB7630 (abiraterone acetate), were presented at the ASCO Genitourinary Cancers Symposium that is ... |